1
0
0
News
vasopharm schließt Finanzierungsrunde über 9,5 Mio. ...GoingPublic.de
www.goingpublic.de
— Christian Wandersee, CEO von vasopharm, kommentierte: „Nach der Empfehlung des Data Monitoring Committee (DMC), die NOSTRA-III-Studie — Christian Wandersee, CEO von vasopharm, kommentierte: „Nach der Empfehlung des Data Monitoring Committee (DMC), die NOSTRA-III-Studie ...
Ascenion GmbH IP Asset ManagementBIO Deutschland
www.biodeutschland.org
Contact Person: Christian Wandersee. Address / PO Box: Friedrich-Bergius-Ring Postal Code / City: Wuerzburg. State: Bavaria. Country: Germany. Contact Person: Christian Wandersee. Address / PO Box: Friedrich-Bergius-Ring Postal Code / City: Wuerzburg. State: Bavaria. Country: Germany.
Deutsche Biotechnologietage 2019Deutsche Biotechnologietage 2024
www.biotechnologietage.de
Christian Wandersee, Vasopharm GmbH | Dr. Holger Zimmermann, AiCuris. Anti-Infective Cures GmbH | Peter Llewellyn-Davis, APEIRON Biologics AG |. Deborah ... Christian Wandersee, Vasopharm GmbH | Dr. Holger Zimmermann, AiCuris. Anti-Infective Cures GmbH | Peter Llewellyn-Davis, APEIRON Biologics AG |. Deborah ...
IMPULSE TGZ Würzburgtgz-wuerzburg.de
www.tgz-wuerzburg.de
Gründer Christian Wandersee (vasopharm GmbH) und Investor Andreas Huber (Bayern Kapital) sprechen über Tipps und Tricks für eine erfolgreiche ... Gründer Christian Wandersee (vasopharm GmbH) und Investor Andreas Huber (Bayern Kapital) sprechen über Tipps und Tricks für eine erfolgreiche ...
Netzwerk-Profile
LinkedIn: Christian Wandersee | LinkedIn
Werden Sie Mitglied von LinkedIn und erhalten Sie Zugriff auf das vollständige Profil von Christian Wandersee. Völlig kostenlos! Als Mitglied von LinkedIn ...
LinkedIn: Christian Wandersee | LinkedIn
Sehen Sie sich das berufliche Profil von Christian Wandersee (Deutschland) auf LinkedIn an. LinkedIn ist das weltweit ... Wandersee. CEO vasopharm GmbH.
LinkedIn: https://at.linkedin.com › christian-se...at.linkedin.comChristian See – Tfzf – Consulting&Coaching
Österreich · Tfzf · Consulting&CoachingChristian Wandersee. Würzburg und Umgebung · Christian See. A&W Indonesia. Jakarta, Indonesien · Christian See. Geschäftsführer. Deutschland · Christian Seeringer.
Interessen
Christian Wandersee - UNITEDNETWORKER Top of the Worldunitednetworker.com
www.unitednetworker.com
Christian Wandersee · Selbstbestimmungsgesetz beschlossen – Proteste vor dem Bundestag · Thailändische Central-Gruppe kauft KaDeWe-Immobilie · Jennison Associates ... Christian Wandersee · Selbstbestimmungsgesetz beschlossen – Proteste vor dem Bundestag · Thailändische Central-Gruppe kauft KaDeWe-Immobilie · Jennison Associates ...
vasopharm Closes €9.5 Million Financing Round | Markets InsiderBusiness Insider
markets.businessinsider.com
Christian Wandersee, Chief Executive Officer of vasopharm, commented: "Following the DMC recommendation to continue the NOSTRA III trial as per protocol, we ... Christian Wandersee, Chief Executive Officer of vasopharm, commented: "Following the DMC recommendation to continue the NOSTRA III trial as per protocol, we ...
vasopharm Closes €9.5 Million Financing RoundMedindia
www.medindia.net
— Christian Wandersee, Chief Executive Officer of vasopharm, commented: "Following the DMC recommendation to continue the NOSTRA III trial as — Christian Wandersee, Chief Executive Officer of vasopharm, commented: "Following the DMC recommendation to continue the NOSTRA III trial as ...
vasopharm Announces Enrolment of First Patient in Phase ...PR Newswire
www.prnewswire.com
— Christian Wandersee, Chief Executive Officer of vasopharm, commented: "We welcome the recruitment of the first patient in to this pivotal — Christian Wandersee, Chief Executive Officer of vasopharm, commented: "We welcome the recruitment of the first patient in to this pivotal ...
Business-Profile
Christian Wandersee (Vasopharm GmbH)life-sciences-uk.com
www.life-sciences-uk.com
Christian Wandersee (Vasopharm GmbH). Wandersee, Christian (Vasopharm GmbH Managing Director). Organisation, Vasopharm GmbH. Product ... Christian Wandersee (Vasopharm GmbH). Wandersee, Christian (Vasopharm GmbH Managing Director). Organisation, Vasopharm GmbH. Product ...
Dokumente zum Namen
BIO Deutschland 2004–2014 JubiläumsjahrbuchBIO Deutschland
www.biodeutschland.org
MagForce AG · Christian Wandersee, Vasopharm GmbH ·. Dr. Wolfgang Weitnauer, Weitnauer Rechtsanwälte · Dr. Jörg. Zätzsch, CMS Hasche Sigle Partnerschaft von ... MagForce AG · Christian Wandersee, Vasopharm GmbH ·. Dr. Wolfgang Weitnauer, Weitnauer Rechtsanwälte · Dr. Jörg. Zätzsch, CMS Hasche Sigle Partnerschaft von ...
einBLICK - OPUS WürzburgOPUS Würzburg
opus.bibliothek.uni-wuerzburg.de
von I für die Schädlingsbekämpfung · — Gründers aus dem IGZ: Christian Wandersee, Geschäftsführer der Firma vasopharm, erzählte von seinen Erfahrungen. Noch als BWL-Student hat ... von I für die Schädlingsbekämpfung · — Gründers aus dem IGZ: Christian Wandersee, Geschäftsführer der Firma vasopharm, erzählte von seinen Erfahrungen. Noch als BWL-Student hat ...
Wissenschaftliche Veröffentlichungen
Würzburger Vasopharm erhält 20 Mio. Euro für Phase-III- ...Science4Life
www.science4life.de
— Die Daten der vorangegangenen Phase II-Studie seien sehr genau analysiert worden, berichtet Firmenchef Christian Wandersee: „Wir glauben — Die Daten der vorangegangenen Phase II-Studie seien sehr genau analysiert worden, berichtet Firmenchef Christian Wandersee: „Wir glauben ...
Science4Life Initialzündung für Unternehmenserfolge -...
www.science4life.de
Christian Wandersee von der vasopharm BIOTECH GmbH, Gewinner der letzten Runde: “Die Prämierung verschafft uns ein kaum zu unterschätzendes Argument gegenüber ...
Universität Würzburg: UNI-INTERN
www.uni-wuerzburg.de
Universität Würzburg: Mitteilungsblatt UNI-INTERN April
hr1-Das Informationsradio wird Medienpartner von Science4Life -...
www.science4life.de
Christian Wandersee wird auch auf der Auftaktpressekonferenz anwesend sein und zu seinen Erfahrungen mit Science4Life berichten. Vom Auftakt der aktuellen Runde ...
Veröffentlichungen allgemein
PharmaTimes – in-depth news, features and insights for the ...Virdis Group
virdisgroup.com
CEO Christian Wandersee explains the hurdles and hopes when developing drugs for traumatic brain injury, a devastating condition for which there is no ... CEO Christian Wandersee explains the hurdles and hopes when developing drugs for traumatic brain injury, a devastating condition for which there is no ...
PRESS RELEASE vasopharm’s Traumatic Brain Injury Drug Exceeds ...
heidelbergcapital.de
WebChristian Wandersee, Chief Executive Officer of vasopharm, commented: “We are very pleased and surprised by these results. Working closely with world experts in TBI, the …
Press release PhaseIIa
heidelbergcapital.de
WebChristian Wandersee CEO vasopharm GmbH Friedrich-Bergius-Ring Wuerzburg – Germany Phone: + Title: Microsoft …
vasopharm completes patient enrollment for Phase III Traumatic …
heidelbergcapital.de
WebChristian Wandersee, CEO Tel: + Optimum Strategic Communications Mary Clark, Eva Haas, Hollie Vile Tel: +44 (0) 203 …
Video & Audio
Detail - BioM
www.bio-m.org
The new capital will be used to commence a phase III study in moderate to severe traumatic brain injury
Würzburger Vasopharm erhält 20 Mio. Euro für Phase-III-Studie - BioM
www.bio-m.org
Mit dem frischen Kapital will Vasopharm seinen am weitesten fortgeschrittenen Produktkandidaten VAS203 gegen traumatische Hirnverletzungen in einer klinischen...
Würzburger Vasopharm sammelt 9,5 Mio € ein für die Zulassungsstudie...
www.bio-m.org
· ... einer möglichen Einreichung klinischer Daten im Jahr abzuschließen", kommentierte Christian Wandersee, CEO von Vasopharm.
Artikel & Meinungen
Twitter-Nachrichten: OptimumCommsX
vasopharm CEO, Christian Wandersee provides an 'Expert View' on the difficulties involved in drug development in #TBI. vasopharm has the most advanced ... vasopharm CEO, Christian Wandersee provides an 'Expert View' on the difficulties involved in drug development in #TBI. vasopharm has the most advanced ...
Updates: #MakeItTen: Interview with vasopharmCreathor Ventures
www.creathor.com
— Make It Ten №5 is with Christian Wandersee, CEO of the most recent investment of our CV IV fund: vasopharm. Hopefully, as a private person — Make It Ten №5 is with Christian Wandersee, CEO of the most recent investment of our CV IV fund: vasopharm. Hopefully, as a private person ...
TFG - Der Pusher-Thread - für Kritiker verboten! Beiträge pro...
www.wallstreet-online.de
Seite 10 der Diskussion 'TFG - Der Pusher-Thread - für Kritiker verboten!' vom im w:o-Forum 'Nebenwerte Deutschland'.
Sonstiges
Christian Wandersee: Positions, Relations and Network ...marketscreener.com
in.marketscreener.com
Presently, Christian Wandersee is Co-Managing Director & Chief Executive Officer at vasopharm GmbH. In the past he was Principal at VARTA BATTERIE AG. Presently, Christian Wandersee is Co-Managing Director & Chief Executive Officer at vasopharm GmbH. In the past he was Principal at VARTA BATTERIE AG.
Erfahrungen von Christian WanderseeMarketScreener
at.marketscreener.com
Hier finden Sie die internationalen, operativen und branchenspezifischen Erfahrungen von Christian Wandersee. 3 bekannte Positionen zusätzlich zu Chief ... Hier finden Sie die internationalen, operativen und branchenspezifischen Erfahrungen von Christian Wandersee. 3 bekannte Positionen zusätzlich zu Chief ...
CEO and Executive Team - VasopharmThe Org
theorg.com
About. Vasopharm's CEO and Executive Team includes Frank Tegtmeier and 2 others. Team members. Christian Wandersee's profile picture. Christian Wandersee. About. Vasopharm's CEO and Executive Team includes Frank Tegtmeier and 2 others. Team members. Christian Wandersee's profile picture. Christian Wandersee.
Leadership Team - VasopharmThe Org
theorg.com
Vasopharm's Leadership Team includes John Stover and 7 others. Team members. Christian Wandersee's profile picture. Christian Wandersee. CEO. Vasopharm's Leadership Team includes John Stover and 7 others. Team members. Christian Wandersee's profile picture. Christian Wandersee. CEO.
Make It Ten: vasopharm - by Thomas DreilingMedium · Thomas Dreilingvor 4 Jahren
medium.com
In Make It Ten №5 we spoke with Christian Wandersee, CEO of vasopharm, the most recent investment out of our CV IV fund. In Make It Ten №5 we spoke with Christian Wandersee, CEO of vasopharm, the most recent investment out of our CV IV fund.
Peter Scheurer Email Address - vasopharm GmbHRocketReach
rocketreach.co
Top vasopharm GmbH Employees ; Christian Wandersee. CEO at vasopharm GmbH. Würzburg, BY, DE ; Frank Tegtmeier. Chief Scientific Officer at vasopharm GmbH. Top vasopharm GmbH Employees ; Christian Wandersee. CEO at vasopharm GmbH. Würzburg, BY, DE ; Frank Tegtmeier. Chief Scientific Officer at vasopharm GmbH.
PharmaTimes - June 2018PharmaTimes
pharmatimes.com
CEO Christian Wandersee explains the hurdles and hopes whe... Is trouble on the horizon for GSK? Ana Nicholls asks whether GSK's revenue drop is a short-te ... CEO Christian Wandersee explains the hurdles and hopes whe... Is trouble on the horizon for GSK? Ana Nicholls asks whether GSK's revenue drop is a short-te ...
Ronopterin - Drug Targets, Indications, PatentsPatsnap Synapse
synapse.patsnap.com
Christian Wandersee, Chief Executive Officer of vasopharm, commented: “Following the DMC recommendation to continue the NOSTRA III trial as per protocol, we ... Christian Wandersee, Chief Executive Officer of vasopharm, commented: “Following the DMC recommendation to continue the NOSTRA III trial as per protocol, we ...
The importance of treating TBIs earlyPharmafile
magazine.pharmafile.com
Christian Wandersee and John Stover from Vasopharm talk to Pharmafile about the effects a Traumatic Brain Injury (TBI) can have on a patient, as well as the ... Christian Wandersee and John Stover from Vasopharm talk to Pharmafile about the effects a Traumatic Brain Injury (TBI) can have on a patient, as well as the ...
Wasserball-in-Baden: 1. Bundesliga Wasserball in Baden
www.wasserball-in-baden.de
... Christian Wandersee SV Krefeld 72 am Wochenende wieder im Doppeleinsatz. Pokalspiel in Hildesheim / Bundesligaduell beim Aufsteiger Poseidon Hamburg Christian Wandersee SV Krefeld 72 am Wochenende wieder im Doppeleinsatz. Pokalspiel in Hildesheim / Bundesligaduell beim Aufsteiger Poseidon Hamburg.
vasopharm BIOTECH GmbH Announces Enrollment Of First ...BioSpace
www.biospace.com
Christian Wandersee, Chief Executive Officer of vasopharm, commented: "We welcome the recruitment of the first patient in to this pivotal phase III trial. Christian Wandersee, Chief Executive Officer of vasopharm, commented: "We welcome the recruitment of the first patient in to this pivotal phase III trial.
vasopharm BIOTECH GmbH Closes Series F Financing RoundBioSpace
www.biospace.com
... Christian Wandersee, CEO of vasopharm. “In the Phase IIa NOSTRA trial, we ... Christian Wandersee, CEO vasopharm GmbH. Phone: + Email Christian Wandersee, CEO of vasopharm. “In the Phase IIa NOSTRA trial, we ... Christian Wandersee, CEO vasopharm GmbH. Phone: + Email ...
vasopharm GmbH - Drug pipelines, Patents, Clinical trialsPatSnap Synapse
synapse.patsnap.com
Christian Wandersee, Chief Executive Officer of vasopharm, commented: “Following the DMC recommendation to continue the NOSTRA III trial as per protocol, we ... Christian Wandersee, Chief Executive Officer of vasopharm, commented: “Following the DMC recommendation to continue the NOSTRA III trial as per protocol, we ...
vasopharm GmbH Management Team | Org ChartRocketReach
rocketreach.co
Christian Wandersee (CEO) | Frank Tegtmeier (Chief Scientific Officer) | Andrew Clark (Chairman) | View more for vasopharm GmbH >>> Christian Wandersee (CEO) | Frank Tegtmeier (Chief Scientific Officer) | Andrew Clark (Chairman) | View more for vasopharm GmbH >>>
vasopharm GmbHDie Deutsche Industrie
www.diedeutscheindustrie.de
Company management. Management. Dr. Frank Tegtmeier Christian Wandersee. Commercial register. HRB 6241, Würzburg. Tax ID no. DE Further ... Company management. Management. Dr. Frank Tegtmeier Christian Wandersee. Commercial register. HRB 6241, Würzburg. Tax ID no. DE Further ...
vasopharm closes EUR9.5m financing roundPrivate Equity Wire
www.privateequitywire.co.uk
Christian Wandersee, Chief Executive Officer of vasopharm, says: “Following the DMC recommendation to continue the NOSTRA III trial as per protocol, we are ... Christian Wandersee, Chief Executive Officer of vasopharm, says: “Following the DMC recommendation to continue the NOSTRA III trial as per protocol, we are ...
veriNOS operations GmbH, WürzburgNorth Data
www.northdata.de
... Christian Wandersee GF Frank Tegtmeier Kapital: € Satzung Kapital: € Kapital: € Kapital: € Kapital: € Satzung Christian Wandersee GF Frank Tegtmeier Kapital: € Satzung Kapital: € Kapital: € Kapital: € Kapital: € Satzung ...
34 Treffer für "Ulrich Walter" im HandelsregisterCompanyhouse
www.companyhouse.de
— Verbundene Manager: Bernd Burger, Christian Wandersee, Frank Tegtmeier · Ulrich Walter, Genthin. Aktiv. 1. Aktive Verbindungen: AWO fair.leben — Verbundene Manager: Bernd Burger, Christian Wandersee, Frank Tegtmeier · Ulrich Walter, Genthin. Aktiv. 1. Aktive Verbindungen: AWO fair.leben ...
Drug Development – Creathor's CornerMedium
medium.com
— In Make It Ten №5 we spoke with Christian Wandersee, CEO of vasopharm, the most recent investment out of our CV IV… Read more… — In Make It Ten №5 we spoke with Christian Wandersee, CEO of vasopharm, the most recent investment out of our CV IV… Read more…
German biotech company vasopharm raises €9.5 million to ...EU-Startups
www.eu-startups.com
— ... Christian Wandersee, CEO of vasopharm. “We are pleased to welcome Creathor Ventures to vasopharm and would like to thank our existing — ... Christian Wandersee, CEO of vasopharm. “We are pleased to welcome Creathor Ventures to vasopharm and would like to thank our existing ...
Verwandte Suchanfragen zu Christian Wandersee
| Ulrich Walter Mary Clark Frank Tegtmeier | Jana Fritz Stefan Haupt Peter Voll | Gabriele Wandersee Klaus Wandersee Guido Stalszus |
Personen Vorname "Christian" (95886) Name "Wandersee" (49) |
sortiert nach Relevanz / Datum